Neurocrine Biosciences reported $32.1M in Net Income for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 766M 2787M
Acadia Pharmaceuticals ACAD:US $ -66.45M 0.31M
Acorda Therapeutics ACOR:US $ -33.45M 49.6M
Adamas Pharmaceuticals ADMS:US -12573000 5.7M
Agios Pharmaceuticals AGIO:US $ -86.22M 1960.54M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Alnylam Pharmaceuticals ALNY:US $ -200.29M 43.25M
Amgen AMGN:US $ 1646M 31M
Aptinyx Inc APTX:US $ -14226000 2.74M
Biogen BIIB:US $ 448.5M 38.3M
Biomarin Pharmaceutical BMRN:US $ 12.94M 4.43M
Cytokinetics CYTK:US $ -47.1M 3.17M
Dynavax Technologies DVAX:US $ 0.89M 16.36M
Enanta Pharmaceuticals ENTA:US $ -22.04M 13.72M
Gilead Sciences GILD:US $ 1522M 207M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Halozyme Therapeutics HALO:US $ 27.9M 45.27M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
Intra Cellular Therapies ITCI:US $ -52.74M 7.96M
Nektar Therapeutics NKTR:US $ -122.97M 5.76M
Neurocrine Biosciences NBIX:US $ 32.1M 315.8M
Pfizer PFE:US $ 5564M 686M
Prothena PRTA:US $ -36.74M 6.02M
Regeneron Pharmaceuticals REGN:US $ 1115.2M 34M
Repligen RGEN:US $ 36.23M 6.78M
Rigel Pharmaceuticals RIGL:US $ 39.5M 58.74M
Sarepta Therapeutics SRPT:US $ -167.25M 22.07M
Teva Pharmaceutical TEVA:IT 207M 129M
Ultragenyx Pharmaceutical RARE:US $ -136.14M 112.13M
Vertex Pharmaceuticals VRTX:US $ 66.92M 586.21M
Xoma XOMA:US $ -7373000 30.04M
YTE INCY:US $ 53.54M 96.32M